National Guideline Clearinghouse | Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer.

full-text ►

National Guideline Clearinghouse | Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer.



Program in Evidence-based Care

Cancer Care Ontario (CCO)

Guideline Title Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer. Bibliographic Source(s) Rodrigues G, Yao X, Loblaw A, Brundage M, Chin J, Genitourinary Cancer Disease Site Group. Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer. Toronto (ON): Cancer Care Ontario (CCO); 2012 Oct 31. 55 p. (Evidence-based series; no. 3-10).  [165 references] Guideline Status This is the current release of the guideline. The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities. Please visit the Cancer Care Ontario Web site  for details on any new evidence that has emerged and implications to the guidelines.